All In Biotech

Free tool

FAERS Monitor: Omnitrope

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 021426 or its brand name (Omnitrope, Somatropin). Reports on generic versions are filed under their own applications.

Reports

17,867

Serious

7,443

42% of reports

Hospitalization

2,489

Death reported

536

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • injection site pain1,811
  • device breakage1,690
  • device leakage1,631
  • incorrect dose administered1,143
  • incorrect dose administered by device1,140
  • device issue963
  • circumstance or information capable of leading to medication error922
  • product dose omission issue913
  • drug dose omission by device822
  • headache814
  • circumstance or information capable of leading to device use error690
  • injection site haemorrhage643
  • off label use634
  • injection site bruising599
  • device mechanical issue596

Reports by year received

View as table
YearReports
200439
200513
200626
2007110
200847
2009216
2010169
2011216
2012233
2013162
2014231
2015495
20161,022
2017915
20181,245
20191,114
20201,000
2021903
20221,068
20231,661
20242,254
20253,307
20261,421

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,292 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
circumstance or information capable of leading to device use errorSignal690481.8441.5234,629
incorrect dose administered by deviceSignal1,14053.550.556,179
device mechanical issueSignal59653.549.329,313
device breakageSignal1,69051.148.879,652
device leakageSignal1,63146.043.969,157
circumstance or information capable of leading to medication errorSignal92233.031.027,850
device issueSignal96312.812.010,364
drug dose omission by deviceSignal82212.511.78,608
injection site haemorrhageSignal6439.58.84,890
injection site bruisingSignal5998.98.24,176
injection site painSignal1,8117.06.79,364
incorrect dose administeredSignal1,1435.95.64,695
product dose omission issueSignal9133.73.41,785
headache8141.51.4153
off label use6340.90.817

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.